Elevated pretransplantation soluble CD30 is associated with decreased early allograft function after human lung transplantation

Human Immunology

Volumn 70, Issue 2, 2009, Pages 101-103

  Shah, Ashish S ^a   Leffell, M Sue ^a   Lucas, Donna ^a   Zachary, Andrea A ^a  

^a NONE

Author keywords

Allograft function; Lung transplantation; Soluble CD30; T cell activation

Indexed keywords

CD30 ANTIGEN;

ADULT; ALLOGRAFT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EMPHYSEMA; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; ISCHEMIA; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; MORTALITY; OXYGENATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD30; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 59649125012     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.12.005     Document Type: Article

References (13)

1. Barr M.L., Kawut S.M., Whelan T.P., Girgis R., Bottcher H., Sonnett J., et al. ISHLT Working Group on Primary Lung Graft Dysfunction: Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV. J Heart Lung Transplant 24 (2005) 1468-1482
2. Arcasoy S.M., Fisher A., Hachem R.R., Scavuzzo M., and Ware L.B. ISHLT Working Group on Primary Lung Graft Dysfunction: Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V. J Heart Lung Transplant 24 (2005) 1483-1487
3. Langan L.L., D'Orsogna L., Park L.P., Hughes T.L., Irish A., Luxton G., et al. HLA antibodies and soluble CD30 are associated with poor renal graft outcome: Updated results of a single center cross-sectional study. Clin Transpl (2006) 219-225
4. Giannoli C., Bonnet M.C., Perrat G., Houillon A., Reydet S., Pouteil-Noble C., et al. High pretransplantation soluble CD30 levels: Impact in renal transplantation. Transplant Proc 39 (2007) 2574-2575
5. Golocheikine A.S., Saini D., Ramachandran S., Trulock E.P., Patterson A., and Mohanakumar T. Soluble CD30 levels as a diagnositic marker for bronchioloitis obliterans syndrome following human lung transplantation. Transplant Immunol 18 (2008) 260-263
6. Bauwens A.M., van de Graff E., van Finkel W.G., van Kessel D.A., and Otten H.G. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 25 (2006) 416-419
7. Fields R.C., Bharat A., Steward N., Aloush A., Meyers B.F., Trulock E.P., et al. Elevated soluble CD30 correlates with the development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 82 (2006) 1596-1601
8. Meyers B.F., de la Morena M., Sweet S.C., Trulock E.P., Guthrie T.J., Mendeloff E.N., et al. Primary graft dysfunction and other selected complications of lung transplantation: A single center experience of 983 patients. J Thorac Cardiovasc Surg 129 (2005) 1421-1429
9. Daud S.A., Yusen R.D., Meyers B.F., Chakinala M.M., Walter M.J., Aloush A.A., et al. Impact of immediate primary allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 175 (2007) 507-513
10. Kaneda H., Waddell T.K., de Perrot M., Bai X.-H., Gutierrez C., Arenovich T., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 6 (2006) 544-551
11. Covarrubias M., Ware L.B., Kawut S.M., De Andrade J., Milstone A., Weinacker A., et al., Lung Transplant Outcomes Group. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 7 (2007) 2573-2578
12. Geudens N., Vanaudenaerde B.M., Neyrinck A.P., Van De Wauwer C., Vos R., Verleden E., et al. The importance of lymphocytes in lung ischemia reperfusion injury. Transplant Proc 39 (2007) 2659-2662
13. de Perrot M., Young K., Imai Y., Liu M., Waddell T.K., Fisher S., et al. Recipient T cells mediate reperfusion injury after lung transplantation in the rat. J Immunol 171 (2003) 4995-5002